vs
和黄医药(HCM)与HEARTLAND EXPRESS INC(HTLD)财务数据对比。点击上方公司名可切换其他公司
和黄医药的季度营收约是HEARTLAND EXPRESS INC的1.5倍($270.8M vs $179.4M),和黄医药净利率更高(0.7% vs -10.8%,领先11.6%),和黄医药同比增速更快(-16.5% vs -26.1%),和黄医药自由现金流更多($3.4M vs $-44.2M)
和黄医药是一家国际化生物制药企业,专注于肿瘤、免疫类疾病的靶向疗法与免疫疗法的研发、生产及商业化,核心市场覆盖中国及全球多个国家地区,已有多款肿瘤治疗药物上市,后期临床管线储备丰富。
哈特兰德快运是一家总部位于艾奥瓦州北利伯蒂的美国公路货运企业,核心业务为覆盖美国全境的整车公路运输服务,在北美干线货运领域拥有稳定的运营网络与行业经验。
HCM vs HTLD — 直观对比
营收规模更大
HCM
是对方的1.5倍
$179.4M
营收增速更快
HCM
高出9.5%
-26.1%
净利率更高
HCM
高出11.6%
-10.8%
自由现金流更多
HCM
多$47.6M
$-44.2M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $270.8M | $179.4M |
| 净利润 | $2.0M | $-19.4M |
| 毛利率 | 37.7% | — |
| 营业利润率 | -13.2% | -12.7% |
| 净利率 | 0.7% | -10.8% |
| 营收同比 | -16.5% | -26.1% |
| 净利润同比 | -83.6% | -949.2% |
| 每股收益(稀释后) | $0.00 | $-0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
HCM
HTLD
| Q4 25 | $270.8M | $179.4M | ||
| Q3 25 | — | $196.5M | ||
| Q2 25 | $277.7M | $210.4M | ||
| Q1 25 | $324.5M | $219.4M | ||
| Q4 24 | — | $242.6M | ||
| Q3 24 | — | $259.9M | ||
| Q2 24 | $305.7M | $274.8M | ||
| Q1 24 | — | $270.3M |
净利润
HCM
HTLD
| Q4 25 | $2.0M | $-19.4M | ||
| Q3 25 | — | $-8.3M | ||
| Q2 25 | $455.0M | $-10.9M | ||
| Q1 25 | $11.9M | $-13.9M | ||
| Q4 24 | — | $-1.9M | ||
| Q3 24 | — | $-9.3M | ||
| Q2 24 | $25.8M | $-3.5M | ||
| Q1 24 | — | $-15.1M |
毛利率
HCM
HTLD
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 41.1% | — | ||
| Q1 24 | — | — |
营业利润率
HCM
HTLD
| Q4 25 | -13.2% | -12.7% | ||
| Q3 25 | — | -3.7% | ||
| Q2 25 | -1.3% | -5.9% | ||
| Q1 25 | -5.0% | -6.8% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | -2.7% | ||
| Q2 24 | -9.0% | 0.1% | ||
| Q1 24 | — | -5.3% |
净利率
HCM
HTLD
| Q4 25 | 0.7% | -10.8% | ||
| Q3 25 | — | -4.2% | ||
| Q2 25 | 163.8% | -5.2% | ||
| Q1 25 | 3.7% | -6.3% | ||
| Q4 24 | — | -0.8% | ||
| Q3 24 | — | -3.6% | ||
| Q2 24 | 8.4% | -1.3% | ||
| Q1 24 | — | -5.6% |
每股收益(稀释后)
HCM
HTLD
| Q4 25 | $0.00 | $-0.24 | ||
| Q3 25 | — | $-0.11 | ||
| Q2 25 | $0.52 | $-0.14 | ||
| Q1 25 | $0.01 | $-0.18 | ||
| Q4 24 | — | $-0.03 | ||
| Q3 24 | — | $-0.12 | ||
| Q2 24 | $0.03 | $-0.04 | ||
| Q1 24 | — | $-0.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $18.5M |
| 总债务越低越好 | $93.2M | $154.1M |
| 股东权益账面价值 | $1.2B | $755.3M |
| 总资产 | $1.8B | $1.2B |
| 负债/权益比越低杠杆越低 | 0.08× | 0.20× |
8季度趋势,按日历期对齐
现金及短期投资
HCM
HTLD
| Q4 25 | $1.4B | $18.5M | ||
| Q3 25 | — | $32.7M | ||
| Q2 25 | $1.4B | $22.9M | ||
| Q1 25 | $836.1M | $23.9M | ||
| Q4 24 | — | $12.8M | ||
| Q3 24 | — | $30.7M | ||
| Q2 24 | $802.5M | $23.9M | ||
| Q1 24 | — | $23.8M |
总债务
HCM
HTLD
| Q4 25 | $93.2M | $154.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | $187.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | — |
股东权益
HCM
HTLD
| Q4 25 | $1.2B | $755.3M | ||
| Q3 25 | — | $775.6M | ||
| Q2 25 | $1.2B | $786.7M | ||
| Q1 25 | $759.9M | $807.7M | ||
| Q4 24 | — | $822.6M | ||
| Q3 24 | — | $825.7M | ||
| Q2 24 | $740.1M | $836.8M | ||
| Q1 24 | — | $848.8M |
总资产
HCM
HTLD
| Q4 25 | $1.8B | $1.2B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | $1.8B | $1.3B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | $1.3B | $1.4B | ||
| Q1 24 | — | $1.5B |
负债/权益比
HCM
HTLD
| Q4 25 | 0.08× | 0.20× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | 0.23× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $8.2M | $14.9M |
| 自由现金流经营现金流 - 资本支出 | $3.4M | $-44.2M |
| 自由现金流率自由现金流/营收 | 1.2% | -24.6% |
| 资本支出强度资本支出/营收 | 1.8% | 33.0% |
| 现金转化率经营现金流/净利润 | 4.21× | — |
| 过去12个月自由现金流最近4个季度 | $-96.2M | $-66.9M |
8季度趋势,按日历期对齐
经营现金流
HCM
HTLD
| Q4 25 | $8.2M | $14.9M | ||
| Q3 25 | — | $27.5M | ||
| Q2 25 | $-72.9M | $21.0M | ||
| Q1 25 | $40.3M | $25.8M | ||
| Q4 24 | — | $37.8M | ||
| Q3 24 | — | $35.6M | ||
| Q2 24 | $-39.8M | $40.0M | ||
| Q1 24 | — | $31.0M |
自由现金流
HCM
HTLD
| Q4 25 | $3.4M | $-44.2M | ||
| Q3 25 | — | $-12.2M | ||
| Q2 25 | $-82.2M | $-12.8M | ||
| Q1 25 | $32.5M | $2.3M | ||
| Q4 24 | — | $-45.5M | ||
| Q3 24 | — | $24.6M | ||
| Q2 24 | $-49.9M | $29.4M | ||
| Q1 24 | — | $26.3M |
自由现金流率
HCM
HTLD
| Q4 25 | 1.2% | -24.6% | ||
| Q3 25 | — | -6.2% | ||
| Q2 25 | -29.6% | -6.1% | ||
| Q1 25 | 10.0% | 1.0% | ||
| Q4 24 | — | -18.8% | ||
| Q3 24 | — | 9.5% | ||
| Q2 24 | -16.3% | 10.7% | ||
| Q1 24 | — | 9.7% |
资本支出强度
HCM
HTLD
| Q4 25 | 1.8% | 33.0% | ||
| Q3 25 | — | 20.2% | ||
| Q2 25 | 3.3% | 16.1% | ||
| Q1 25 | 2.4% | 10.7% | ||
| Q4 24 | — | 34.3% | ||
| Q3 24 | — | 4.2% | ||
| Q2 24 | 3.3% | 3.8% | ||
| Q1 24 | — | 1.7% |
现金转化率
HCM
HTLD
| Q4 25 | 4.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | 3.38× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.54× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图